Ingevity Corp buy BMO Capital Markets
Start price
05.09.25
/
50%
€51.00
Target price
05.09.26
€58.30
Performance (%)
-4.39%
Price
19.12.25
€50.25
Summary
This prediction is currently active. With a performance of -4.39%, the BUY prediction for Ingevity Corp by BMO_Capital_Markets is down slightly. This prediction currently runs until 05.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -1.760% | -1.760% |
| iShares Core DAX® | 0.299% | 4.557% |
| iShares Nasdaq 100 | 0.666% | 2.752% |
| iShares Nikkei 225® | -0.656% | 0.000% |
| iShares S&P 500 | 0.352% | 1.854% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat